Delivery Order SPE2DE24D0013-SPE2D626F928F
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, has been awarded a delivery order valued at $16,381 by the Defense Logistics Agency Medical Supply Chain for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic supplies. The delivery order, issued on November 12, 2025, with an ultimate completion date of November 19, 2025, utilizes a firm fixed-price structure with no set-aside designation. This award represents a continuation of...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $3,740 on October 26, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as XPCOV2/FLU/RSV-10, is structured as a firm fixed-price delivery order with an ultimate completion date of November 7, 2025, and carries no set-aside designation. This delivery order represents a continuation of Cepheid's extensive federal...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a firm fixed-price delivery order valued at $8,603.68 by the Defense Logistics Agency Medical Supply Chain on October 23, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, calls for diagnostic reagents and test kits for the GeneXpert platform, specifically for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Work will be performed in Sunnyvale, California,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a $68,000 firm fixed-price delivery order (Contract No. 4569923609, XPCOV2/FLU/RSV-10) by the Defense Logistics Agency Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 13, 2025. The delivery order, which carries no set-aside designation, is for diagnostic reagents and test kits related to COVID-19, influenza, and respiratory syncytial virus (RSV)...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $4,080 by the Defense Logistics Agency's Medical Supply Chain on November 24, 2025, with an ultimate completion date of December 2, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test cartridges for the detection of COVID-19, influenza, and respiratory syncytial virus. This award carries no set-aside designation and represents a...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,400 by the Defense Logistics Agency (a component of the Department of Defense) on August 4, 2025, with a completion date of August 11, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves firm fixed-price procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This...
- Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, was awarded a delivery order valued at $2,040 on December 1, 2025, by the Defense Logistics Agency Medical Supply Chain. The delivery order, designated XPCOV2/FLU/RSV-10, carries a firm fixed-price structure with no set-aside designation and is scheduled for completion by December 8, 2025. Performance will take place at Cepheid's Sunnyvale facility. This delivery order represents procurement of diagnostic testing...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $4,080 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on November 10, 2025, with an ultimate completion date of November 18, 2025. The delivery order, designated 4569971783 and titled XPCOV2/FLU/RSV-10, procures diagnostic testing supplies and reagents for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F928FDelivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $40,800 by the Defense Logistics Agency Medical Supply Chain on December 8, 2025, for diagnostic supplies supporting COVID-19, influenza, and respiratory syncytial virus (RSV) testing capabilities. The delivery order, designated XPCOV2/FLU/RSV-10, carries a firm fixed-price structure with an ultimate completion date of December 15, 2025, and is not subject to any small business set-aside designation. Performance will be executed at Cepheid's headquarters location in Sunnyvale, California. This delivery order represents a routine procurement under Cepheid's established relationship with the Defense Logistics Agency, which has issued multiple delivery orders for diagnostic testing supplies and reagents to support federal healthcare operations. Cepheid has established itself as a primary federal supplier of rapid molecular diagnostic testing solutions through its GeneXpert diagnostic platform, serving multiple federal agencies including the Department of Veterans Affairs, Indian Health Service, and Defense Health Agency. The company's extensive portfolio of federal contracts—including significant indefinite delivery contracts with the VA valued in the tens of millions of dollars—demonstrates substantial competitive positioning in federal molecular diagnostics procurement, with all awards utilizing firm fixed-price contracting structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.8k | 12/7/25 |